Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Exheus logo — Exheus analyzes gene activation and metabolic routes through...

Exheus

Exheus analyzes gene activation and metabolic routes through RNA sequencing and AI for personalized health recommendations.

Founded 2020 11-50 employees Pre Seed Total: $650.00K Health Care

General Information

Company Name Exheus
Founded Year 2020
Employees 11-50
Industries Health Care
Funding Stage Pre Seed
Social

Get notified when Exheus moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Exheus

Exheus is a healthcare startup founded in 2020, specializing in personalized health recommendations through gene activation and metabolic pathway analysis. By employing RNA sequencing and Artificial Intelligence, the company conducts a comprehensive examination of all 22,000 genes in the human genome. Their advanced AI algorithms enable the assessment of gene expression levels under varying conditions. A notable aspect of Exheus is its lineage as a spin-off of the Sant Pau Hospital Research Institute, the Polytechnic University of Catalonia (UPC), and the Mobile World Capital. The most recent financial milestone for Exheus was a €650.00K Pre Seed Round investment on 29 November 2022. This investment round saw participation from prominent backers, including Decelera, WA4STEAM, and Capital Cell. An array of compelling factors, such as the incorporation of groundbreaking technologies like RNA sequencing and AI, as well as the strong backing from reputable investors, positions Exheus as a notable player in the healthcare industry.

Taxonomy: RNA sequencing, Health technology, Personalized health, Metabolic pathway analysis, Gene expression analysis, Health recommendations, Research and development, Genomic analysis, Healthcare innovation

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Pre Seed Round •••••• 3
Investor Investor
•••• •••• 		29 Nov 2022
Non Equity Assistance •••••• 1 •••• •••• 31 May 2021

Exheus Alternatives & Competitors

Exheus vs
Accelagen
Accelagen

Accelagen is a fast growing Gene-to-Protein company. Accelagen’s gene-to-protein platform integrates...

7 employees
Biotechnology, Health Care
Exheus vs
LogicBio Therapeutics
LogicBio Therapeutics United States

Develops gene therapy vectors for previously incurable genetic and infectious diseases including hem...

Acquired
13 employees
Biotechnology
Exheus vs
SineuGene Therapeutics
SineuGene Therapeutics China

Bridging the gaps between gene therapy and brain disorders.

Seed
1 employees
Biotechnology, Health Care

FAQ About Exheus

Exheus analyzes gene activation and metabolic routes through RNA sequencing and AI for personalized health recommendations.
Exheus was founded in 2020.
Exheus operates in the following industries: Health Care.
Exheus has approximately 11-50 employees.
Exheus has completed 2 funding rounds, raising a total of $650.00K. The latest funding stage is Pre Seed.
Top alternatives and competitors to Exheus include Accelagen, LogicBio Therapeutics, SineuGene Therapeutics, Gene Universal Inc., Genometry, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Exheus and Accelagen are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Exheus and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy